๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Ramipril - Medicines in Ireland

32 authorised products containing Ramipril, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 32 authorised medicines
MedicineActive substanceLicence holderStatus
Ramilo 1.25 mg tablets
PA0711/063/001
Ramipril Rowex Limited, Marketed
Ramilo 10 mg Tablets
PA0711/063/004
Ramipril Rowex Limited, Marketed
Ramilo 2.5 mg tablets
PA0711/063/002
Ramipril Rowex Limited, Marketed
Ramilo 5 mg tablets
PA0711/063/003
Ramipril Rowex Limited, Marketed
Ramipril Krka 1.25 mg tablets
PA1347/042/001
Ramipril KRKA, d.d., Novo mesto Marketed
Ramipril Krka 10 mg tablets
PA1347/042/004
Ramipril KRKA, d.d., Novo mesto Marketed
Ramipril Krka 2.5 mg tablets
PA1347/042/002
Ramipril KRKA, d.d., Novo mesto Marketed
Ramipril Krka 5 mg tablets
PA1347/042/003
Ramipril KRKA, d.d., Novo mesto Marketed
Ramipril Teva Pharma 1.25mg Tablets
PA0749/177/001
Ramipril Teva Pharma B.V. Marketed
Ramipril Teva Pharma 10mg Tablets
PA0749/177/004
Ramipril Teva Pharma B.V. Marketed
Ramipril Teva Pharma 2.5mg Tablets
PA0749/177/002
Ramipril Teva Pharma B.V. Marketed
Ramipril Teva Pharma 5mg Tablets
PA0749/177/003
Ramipril Teva Pharma B.V. Marketed
Ramitace 10mg Tablets
PA0126/163/003
Ramipril Clonmel Healthcare Ltd Marketed
Ramitace 2.5mg Tablets
PA0126/163/001
Ramipril Clonmel Healthcare Ltd Marketed
Ramitace 5 mg tablets
PA0126/163/002
Ramipril Clonmel Healthcare Ltd Marketed
Triapin 2.5mg/2.5mg prolonged release tablet
PA0540/082/001
Felodipine, Ramipril Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Triapin 5 mg/5 mg prolonged release tablets
PPA1463/098/001
Felodipine, Ramipril IMED Healthcare Ltd., โ€”
Triapin 5 mg/5 mg prolonged release tablets
PPA23080/015/001
Felodipine, Ramipril Merit Pharmaceuticals Limited โ€”
Triapin 5mg/5mg prolonged release tablet
PA0540/082/002
Felodipine, Ramipril Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Trinomia 100 mg/20 mg/10 mg hard capsules
PA1744/002/003
Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate Ferrer Internacional, S.A Marketed
Trinomia 100 mg/20 mg/2.5 mg hard capsules
PA1744/002/001
Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate Ferrer Internacional, S.A Marketed
Trinomia 100 mg/20 mg/5 mg hard capsules
PA1744/002/002
Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate Ferrer Internacional, S.A Marketed
Trinomia 100 mg/40 mg/10 mg hard capsules
PA1744/002/006
Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate Ferrer Internacional, S.A Marketed
Trinomia 100 mg/40 mg/2.5 mg hard capsules
PA1744/002/004
Acetylsalicylic acid, Ramipril, Atorvastatin Ferrer Internacional, S.A Marketed
Trinomia 100 mg/40 mg/5 mg hard capsules
PA1744/002/005
Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate Ferrer Internacional, S.A Marketed
TRITACE 1.25 mg Tablets
PA0540/084/005
Ramipril Sanofi-Aventis Ireland Limited T/A SANOFI Not marketed
Tritace 10 mg Tablets
PA0540/084/008
Ramipril Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Tritace 2.5 mg Tablets
PA0540/084/006
Ramipril Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Tritace 5 mg Tablets
PA0540/084/007
Ramipril Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Twilev 10 mg/5 mg film-coated tablets
PA0865/022/003
Ramipril, Nebivolol hydrochloride Menarini International Operations Luxembourg S.A. Not marketed
Twilev 2.5 mg/5 mg film-coated tablets
PA0865/022/001
Ramipril, Nebivolol hydrochloride Menarini International Operations Luxembourg S.A. Not marketed
Twilev 5 mg/5 mg film-coated tablets
PA0865/022/002
Ramipril, Nebivolol hydrochloride Menarini International Operations Luxembourg S.A. Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.